TCL is co-lead counsel in an antitrust litigation against pharmaceutical manufacturer Pfizer that recently settled for $39 million. Plaintiffs, direct purchasers of the brand name prescription drug Effexor, allege that Pfizer and Teva Pharmaceuticals entered into a “pay for delay” agreement where Pfizer made large payments to Teva in exchange for Teva’s agreement to delay […]
TCL Settles Antitrust Litigation Against Pfizer Read More »